Wednesday, March 24, 2021

Helius Medical Technologies (HSDT)(HSM:CA)
Helius Medical – An Innovative Approach to Neurostimulation

Helius Medical Technologies Inc are a medical technology company. It is focused on the development of products for the treatment of neurological symptoms caused by disease or trauma. The company has developed its first, known as the portable neuromodulation stimulator or PoNS, device, is designed to enhance the brain’s ability to compensate for this damage.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Initiating Coverage. We are initiating research coverage on Helius Medical Technologies. Through its PoNS device and treatment program, we believe Helius has a first mover advantage in using the tongue for neurostimulation to reduce symptoms of neurological disease or trauma.


PoNS Treatment.  The Portable Neuromodulation Stimulator, or PoNS, is a non-implantable, medical device intended as a short-term treatment of gait deficit due to symptoms from MS and balance deficit due to mmTBI and is to be used in conjunction with physical therapy. PoNS makes use of the tongue as a means neurostimulation. Helius has an extensive patent portfolio on use of the tongue for …

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision.